Abstract
Two recently discovered genes involved in ALS could reveal the pathways that are central to the neurodegeneration caused by the disease. But as some researchers storm ahead suggesting treatments targeting these genes, others are questioning how relevant the reports are for nonheritable forms of the disease. Virginia Hughes investigates why the new findings seem to have struck a nerve in the ALS community.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
